A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
מצבים רפואיים
Psoriasis · Overweight or Obesity
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Medical Dermatology Specialists, Phoenix, Arizona, United States
Contact: Principal Investigator (Lindsay Ackerman)First OC Dermatology Research Inc, Fountain Valley, California, United States
Contact: Principal Investigator (Vivian Laquer)Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Contact: Principal Investigator (Sunil Dhawan)Metropolis Dermatology, Los Angeles, California, United States
Contact: Principal Investigator (Yen (James) Wang)Northridge Clinical Trials, Northridge, California, United States
Contact: Principal Investigator (Navid Ezra)NeoClinical Research, Hialeah, Florida, United States
Contact: Principal Investigator (Martin Zaiac, MD)Skin Care Research, Hollywood, Florida, United States
Contact: Principal Investigator (Eduardo Weiss)Encore Medical Research, Hollywood, Florida, United States
Contact: Principal Investigator (Jerome Obed)MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa, Florida, United States
Contact: Principal Investigator (Stephen Lockwood)TruDerm & TruSpa, Wellington, Florida, United States
Contact: Principal Investigator (Andleeb Usmani)Southeast Research Specialists, Douglasville, Georgia, United States
Contact: Principal Investigator (Firas George Hougeir)Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
Contact: Principal Investigator (Scott Fretzin)The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Contact: Principal Investigator (Scott Guenthner)Equity Medical - Bowling Green, Bowling Green, Kentucky, United States
Contact: Principal Investigator (James Allred)Dermatology and Skin Cancer Specialists, LLC, Rockville, Maryland, United States
Contact: Principal Investigator (Benjamin Lockshin)Metro Boston Clinical Partners, Brighton, Massachusetts, United States
Contact: Principal Investigator (Mark Amster)David Fivenson, MD, PLC, Ann Arbor, Michigan, United States
Contact: Principal Investigator (David Fivenson)Great Lakes Research Group, Inc., Bay City, Michigan, United States
Contact: Principal Investigator (Brent Boyce)The Derm Institute of West Michigan, Caledonia, Michigan, United States
Contact: Principal Investigator (Kristi Hawley)Skin Cancer and Dermatology Institute - Reno, Reno, Nevada, United States
Contact: Principal Investigator (Michael Heaphy)Stracskin, Portsmouth, New Hampshire, United States
Contact: Principal Investigator (Abel Jarell)Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, United States
Contact: Principal Investigator (Alexa Hetzel)Care Access - Hoboken, Hoboken, New Jersey, United States
Contact: Principal Investigator (Adolfo Fernandez- Obregon)Equity Medical, New York, New York, United States
Contact: Principal Investigator (Michael Cameron)Revival Research Institute, LLC, Cary, North Carolina, United States
Contact: Principal Investigator (Zain Husain)Onsite Clinical Solutions - Huntersville, Huntersville, North Carolina, United States
Contact: Principal Investigator (Nicole Seminara-Zambrzycka)Optima Research - Boardman, Boardman, Ohio, United States
Contact: Principal Investigator (Patrick Shannon)Oregon Dermatology and Research Center, Portland, Oregon, United States
Contact: Principal Investigator (Phoebe Rich, MD)Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, United States
Contact: Principal Investigator (Jonathan Wolfe)Columbia Dermatology & Aesthetics, Columbia, South Carolina, United States
Contact: Principal Investigator (Jessica Burgy)DelRicht Research - Thompson's Station, Smyrna, Tennessee, United States
Contact: Principal Investigator (Pezhman Shoureshi)Bellaire Dermatology Associates, Bellaire, Texas, United States
Contact: Principal Investigator (Craig Teller)Modern Research Associates, PLLC, Dallas, Texas, United States
Contact: Principal Investigator (Jennifer Cather)Center for Clinical Studies, Houston, Texas, United States
Contact: Principal Investigator (Stephen Tyring)Austin Institute for Clinical Research, Pflugerville, Texas, United States
Contact: Principal Investigator (Edward Lain)Texas Dermatology and Laser Specialists, San Antonio, Texas, United States
Contact: Principal Investigator (John Browning)Center for Clinical Studies, Webster, Texas, United States
Contact: Principal Investigator (PATRICIA LEE)Tanner Clinic, Layton, Utah, United States
Contact: Principal Investigator (Scott Checketts)Bellevue Dermatology Clinic, Bellevue, Washington, United States
Contact: Principal Investigator (Clive Liu)Dermatology of Seattle, Burien, Washington, United States
Contact: Principal Investigator (Elie Levy)
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company